11 terminated. 11 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Terminated 11 |
| Phase 1 | 1 | Terminated 1 |
Follow Protein expression analysis: new trials by email Literature Review of Protein expression analysis trials Research Report on Protein expression analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brivanib Metastatic Renal Cell Carcinoma Brivanib alaninate, Polymerase chain reaction, Iodine I 124 chimeric monoclonal antibody G250 - Renal Cell Carcinoma | Phase 2 | Terminated | Abramson Cancer Center at Penn Medicine | 10 | 2011-11-01 | 2021-04-13 |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia clofarabine, daunorubicin hydrochloride, cytogenetic analysis - Leukemia | Phase 2 | Terminated | Roswell Park Cancer Institute | 21 | 2008-12-01 | 2016-08-17 |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction - Kaposi's Sarcoma | Phase 1 / Phase 2 | Terminated | AIDS Malignancy Consortium | 17 | 2008-09-01 | 2018-06-06 |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer SOD1 inhibitor ATN-224, exemestane, protein expression analysis - Breast Cancer | Phase 2 | Terminated | Cancer Research UK | 111 | 2008-06-01 | 2013-07-10 |
| Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery erlotinib hydrochloride, conventional surgery, immunohistochemistry staining method - Intraductal Papillary Mucinous Neoplasm of the Pancreas, Recurrent Pancreatic Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 6 | 2007-06-01 | 2014-10-16 |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy calcitriol, dexamethasone, protein expression analysis - Prostate Cancer | Phase 2 | Terminated | Roswell Park Cancer Institute | 18 | 2006-04-01 | 2017-11-20 |
| Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer gemcitabine hydrochloride, imatinib mesylate, gene expression analysis - Kidney Cancer | Phase 2 | Terminated | University of Medicine and Dentistry of New Jersey | 100 | 2006-04-01 | 2009-12-11 |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery filgrastim, capecitabine, celecoxib - Breast Cancer | Phase 2 | Terminated | University of Nebraska | 3 | 2004-04-15 | 2023-09-13 |
| Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer docetaxel, protein expression analysis, laboratory biomarker analysis - Breast Cancer | Phase 2 | Terminated | Vanderbilt-Ingram Cancer Center | 34 | 2004-02-01 | 2012-04-27 |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy recombinant interferon alfa-2b, docetaxel, estramustine phosphate sodium - Prostate Cancer | Phase 2 | Terminated | University of Medicine and Dentistry of New Jersey | 40 | 2002-11-01 | 2009-12-11 |
| Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma filgrastim, dexrazoxane hydrochloride, doxorubicin hydrochloride - Sarcoma | Phase 2 | Terminated | City of Hope Medical Center | 7 | 2001-08-01 | 2014-08-28 |
Breast Neoplasms (3) · Carcinoma, Renal Cell (2) · Prostatic Neoplasms (2) · AIDS-related Kaposi sarcoma (1) · Congenital Abnormalities (1) · HIV Infections (1) · Inflammatory Breast Neoplasms (1) · Kidney Neoplasms (1) · Leukemia (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Neuroectodermal Tumors, Primitive, Peripheral (1)
Roswell Park Cancer Institute (2) · University of Medicine and Dentistry of New Jersey (2) · AIDS Malignancy Consortium (1) · Abramson Cancer Center at Penn Medicine (1) · Cancer Research UK (1) · City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · University of Nebraska (1) · Vanderbilt-Ingram Cancer Center (1)
United States (9) · United Kingdom (1)
A. Bapsi Chakravarthy, MD (1) · Adrian L. Harris, MD (1) · Donald L. Trump, MD (1) · Elizabeth C. Reed, MD (1) · Mark Stein, MD (1) · Meir Wetzler, MD (1) · Robert S. DiPaola, MD (1) · Stephen Keefe, MD (1) · Steven M Lipkin, MD,PhD (1) · Susan E. Krown, MD (1) · Warren A. Chow, MD (1)
P30CA072720 (2), N01CN35160 (1), P30CA033572 (1), P30CA036727 (1), U01CA121947 (1)